Showing results (401-410 of 415) with videos related to
Sort By:
Pageof 42
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.Nature Nanotechnology|May 13, 2014
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightJames E Dahlman, Carmen Barnes, Omar Khan, et al.Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.Science Advances|June 25, 2025
PET-based immunomapping of intratumoral CD4+ cells to monitor acquired resistance to checkpoint inhibitorsStefania Pezzana, Simone Blaess, Bjoern Traenkle, et al.Plant Physiology|June 14, 2003
Identification of Arabidopsis rat mutantsYanmin Zhu, Jaesung Nam, Jaime M Humara, et al.Nature Immunology|October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionAnnika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron VariantsDaniel Junker, Matthias Becker, Teresa R Wagner, et al.European Heart Journal|September 3, 2025
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery diseaseMoritz von Scheidt, Shaunak S Adkar, Johannes Krefting, et al.Nature Communications|January 11, 2022
Robust and durable serological response following pediatric SARS-CoV-2 infectionHanna Renk, Alex Dulovic, Alina Seidel, et al.Nature Biotechnology|July 24, 2020
Author Correction: A robust benchmark for detection of germline large deletions and insertionsJustin M Zook, Nancy F Hansen, Nathan D Olson, et al.Pageof 42